2018
DOI: 10.7717/peerj.5805
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease

Abstract: Congenital heart disease (CHD) affects a considerable number of children and adults worldwide. This implicates not only developmental disorders, high mortality, and reduced quality of life but also, high costs for the healthcare systems. CHD refers to a variety of heart and vascular malformations which could be very challenging to reconstruct the malformed region surgically, especially when the patient is an infant or a child. Advanced technology and research have offered a better mechanistic insight on the im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 159 publications
(250 reference statements)
0
14
0
Order By: Relevance
“…Tissue engineering is a sub-discipline of biomedical engineering that deals with the artificial fabrication of human tissue through the design of tissue scaffolds that accommodate cellular differentiation and proliferation [114]. Moreover, with the rapid progress in research, tissue engineering approaches show great potential for treating CHD [115]. For instance, tissue engineered bovine tissue pericardium scaffolds have been found to be cost-effective and durable, making them great for use in surgeries to treat CHD.…”
Section: H Cost-effective Solutions For Congenital Birth Defectsmentioning
confidence: 99%
“…Tissue engineering is a sub-discipline of biomedical engineering that deals with the artificial fabrication of human tissue through the design of tissue scaffolds that accommodate cellular differentiation and proliferation [114]. Moreover, with the rapid progress in research, tissue engineering approaches show great potential for treating CHD [115]. For instance, tissue engineered bovine tissue pericardium scaffolds have been found to be cost-effective and durable, making them great for use in surgeries to treat CHD.…”
Section: H Cost-effective Solutions For Congenital Birth Defectsmentioning
confidence: 99%
“…In recent years, engineering of prosthetic grafts with regenerative cells, such as mesenchymal stem cells (MSCs), has emerged as a potential solution ( 5 , 6 ). However, MSCs represent a heterogeneous population characterized by wide diversity across different tissue sources.…”
Section: Introductionmentioning
confidence: 99%
“…Despite significant progress in the development of various materials to make cardiac patches, including Dacron (3), Gore-Tex (4) and autologous (5) or bovine pericardium (6), significant drawbacks exist, including increased risk of immune response (7), calcification (6), thrombosis (8,9) and the lack of growth potential (10). Moreover, these materials may become fibrous calcified tissues that cannot degrade, thereby preventing simultaneous growth within the heart and loss of function over time (11). Hence, patients typically require reoperation, which may cause delayed recovery and could result in an increased economic burden to both the family and society (11).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, these materials may become fibrous calcified tissues that cannot degrade, thereby preventing simultaneous growth within the heart and loss of function over time (11). Hence, patients typically require reoperation, which may cause delayed recovery and could result in an increased economic burden to both the family and society (11). Therefore, optimal materials for heart patches should be able to inhibit the immune response, calcification and thrombosis, and support growth of native tissue (10).…”
Section: Introductionmentioning
confidence: 99%